Prof. Dr. med. Bertold Renner

Professor
NameMr Prof. Dr. med. Bertold Renner
Stellvertretender Direktor
Send encrypted mail via the SecureMail portal (for TUD external users only).
Postal Address:
Technische Universität Dresden Institut für Klinische Pharmakologie Fetscherstraße 74
01307 Dresden
Institut für Klinische Pharmakologie Medizinische Fakultät Carl Gustav Carus Technische Universität Dresden
Veröffentlichungen (Auswahl)
-
Stadlbauer A, Oberndorfer S, Zimmermann M, Renner B, Buchfelder M, Heinz G, Doerfler A, Kleindienst A, Roessler K: Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans. J Cereb Blood Flow Metab (2019)
-
Geith S, Renner B, Rabe C, Stenzel J, Eyer F: Ibuprofen plasma concentration profile in deliberate ibuprofen overdose with circulatory depression treated with therapeutic plasma exchange: a case report. BMC Pharmacol Toxicol (2017) 18: 81.
-
Stadlbauer A, Kaltenhäuser M, Buchfelder M, Brandner S, Neuhuber WL, Renner B. Spatio-temporal pattern of human cortical and subcortical activity during early-stage odor processing. Chem.Senses (2016) 41: 783-794.
-
Mrochen A, Marxreiter F, Kohl Z, Schlachetzki J, Renner B, Schenk T, Winkler J, Klucken J. From sweet to sweat: Hedonic olfactory range is impaired in Parkinson's disease. Parkinsonism Relat Disord. (2016) 22: 9-14.
-
Stadlbauer A, Pichler P, Karl M, Brandner S, Lerch C, Renner B, Heinz G. Quantification of serial changes in cerebral blood volume and metabolism in patients with recurrent glioblastoma undergoing antiangiogenic therapy. Eur J Radiol (2015) 84: 1128-1136.
-
Muller F, Pontones CA, Renner B, Mieth M, Hoier E, Auge D, Maas R, Zolk O, Fromm MF. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction. Eur J Clin Pharmacol (2015) 71: 85-94.
-
Renner B, Ahne G, Grosan E, Kettenmann B, Kobal G, Shephard A. Tonic stimulation of the pharyngeal mucosa causes pain and a reversible increase of inflammatory mediators. Inflamm.Res. (2013) 62:1045-1051
-
Radtke S, Zolk O, Renner B, Paulides M, Zimmermann M, Moricke A, Stanulla M, Schrappe M, Langer T. Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia. Blood (2013) 121:5145-5153
-
Kuster M, Renner B, Oppel P, Niederweis U, Brune K. Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study. BMJ Open. (2013) 3:
-
Renner B, Walter G, Strauss J, Fromm MF, Zacher J, Brune K. Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief. Eur.J.Pain (2012) 16:838-848
-
Renner B, Zacher J, Buvanendran A, Walter G, Strauss J, Brune K. Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery--a pilot study. Naunyn-Schmied.Arch.Pharmacol. (2010) 381:127-136
-
Hinz B, Renner B, Cheremina O, Besz D, Zolk O, Brune K. Lumiracoxib inhibits cyclo-oxygenase 2 completely at the 50 mg dose: is liver toxicity avoidable by adequate dosing? Ann.Rheum.Dis. (2009) 68:289-291
-
Renner B, Mueller CA, Dreier J, Faulhaber S, Rascher W, Kobal G. The candy smell test: a new test for retronasal olfactory performance. Laryngoscope (2009) 119:487-495
-
Eberl S, Renner B, Neubert A, Reisig M, Bachmakov I, König J, Dörje F, Mürdter TE, Ackermann A, Dormann H, Gassmann KG, Hahn EG, Zierhut S, Brune K, Fromm MF. Role of P-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies. Clin.Pharmacokinet. (2007) 46:1039-1049
-
Renner B, Clarke G, Grattan T, Beisel A, Mueller C, Werner U, Kobal G, Brune K. Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. J.Clin.Pharmacol. (2007) 47:715-726
-
Hinz B, Cheremina O, Bachmakov J, Renner B, Zolk O, Fromm MF, Brune K. Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic. FASEB J. (2007) 21:2343-2351